227 related articles for article (PubMed ID: 18458136)
21. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
22. In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata.
Oliveira ER; Fothergill AW; Kirkpatrick WR; Coco BJ; Patterson TF; Redding SW
Antimicrob Agents Chemother; 2005 Aug; 49(8):3544-5. PubMed ID: 16048980
[TBL] [Abstract][Full Text] [Related]
23. Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
Lindberg E; Hammarström H; Ataollahy N; Kondori N
Sci Rep; 2019 Mar; 9(1):3838. PubMed ID: 30846717
[TBL] [Abstract][Full Text] [Related]
24. Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Candida species to anidulafungin, caspofungin, and micafungin.
Pfaller M; Boyken L; Hollis R; Kroeger J; Messer S; Tendolkar S; Diekema D
J Clin Microbiol; 2011 Feb; 49(2):624-9. PubMed ID: 21147948
[TBL] [Abstract][Full Text] [Related]
25. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.
Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2008 Jan; 46(1):150-6. PubMed ID: 18032613
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the Sensititre Yeast One microdilution method for susceptibility testing of Candida species to anidulafungin, caspofungin, and micafungin.
García-Agudo L; García-Martos P; Martos-Cañadas J; Aznar-Marín P; Marín-Casanova P; Rodríguez-Iglesias M
Rev Esp Quimioter; 2012 Dec; 25(4):256-60. PubMed ID: 23303256
[TBL] [Abstract][Full Text] [Related]
27. Differential in vivo activities of anidulafungin, caspofungin, and micafungin against Candida glabrata isolates with and without FKS resistance mutations.
Arendrup MC; Perlin DS; Jensen RH; Howard SJ; Goodwin J; Hope W
Antimicrob Agents Chemother; 2012 May; 56(5):2435-42. PubMed ID: 22354305
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.
Diekema DJ; Messer SA; Boyken LB; Hollis RJ; Kroeger J; Tendolkar S; Pfaller MA
J Clin Microbiol; 2009 Oct; 47(10):3170-7. PubMed ID: 19710283
[TBL] [Abstract][Full Text] [Related]
29. Caspofungin activity against clinical isolates of fluconazole-resistant Candida.
Pfaller MA; Messer SA; Boyken L; Rice C; Tendolkar S; Hollis RJ; Diekema DJ
J Clin Microbiol; 2003 Dec; 41(12):5729-31. PubMed ID: 14662968
[TBL] [Abstract][Full Text] [Related]
30. Anidulafungin and micafungin MIC breakpoints are superior to that of caspofungin for identifying FKS mutant Candida glabrata strains and Echinocandin resistance.
Shields RK; Nguyen MH; Press EG; Updike CL; Clancy CJ
Antimicrob Agents Chemother; 2013 Dec; 57(12):6361-5. PubMed ID: 24060873
[TBL] [Abstract][Full Text] [Related]
31. Antifungal susceptibility profile of invasive
Memon S; Farooqi J; Zafar U; Naqvi SF; Zafar A; Jabeen K
J Med Microbiol; 2021 Dec; 70(12):. PubMed ID: 34878377
[No Abstract] [Full Text] [Related]
32. In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method.
Pfaller MA; Hata K; Jones RN; Messer SA; Moet GJ; Castanheira M
Diagn Microbiol Infect Dis; 2011 Oct; 71(2):167-70. PubMed ID: 21696907
[TBL] [Abstract][Full Text] [Related]
33.
Fakhim H; Chowdhary A; Prakash A; Vaezi A; Dannaoui E; Meis JF; Badali H
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848002
[TBL] [Abstract][Full Text] [Related]
34. Activity of Combined Antifungal Agents Against Multidrug-Resistant Candida glabrata Strains.
Denardi LB; Keller JT; Oliveira V; Mario DAN; Santurio JM; Alves SH
Mycopathologia; 2017 Oct; 182(9-10):819-828. PubMed ID: 28493006
[TBL] [Abstract][Full Text] [Related]
35. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.
Miranda-Zapico I; Eraso E; Hernández-Almaraz JL; López-Soria LM; Carrillo-Muñoz AJ; Hernández-Molina JM; Quindós G
J Antimicrob Chemother; 2011 Oct; 66(10):2315-22. PubMed ID: 21795259
[TBL] [Abstract][Full Text] [Related]
37. Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait.
Al-Baqsami ZF; Ahmad S; Khan Z
Sci Rep; 2020 Apr; 10(1):6238. PubMed ID: 32277126
[TBL] [Abstract][Full Text] [Related]
38. Optimizing Echinocandin dosing and susceptibility breakpoint determination via in vivo pharmacodynamic evaluation against Candida glabrata with and without fks mutations.
Lepak A; Castanheira M; Diekema D; Pfaller M; Andes D
Antimicrob Agents Chemother; 2012 Nov; 56(11):5875-82. PubMed ID: 22948870
[TBL] [Abstract][Full Text] [Related]
39. Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance.
Pham CD; Iqbal N; Bolden CB; Kuykendall RJ; Harrison LH; Farley MM; Schaffner W; Beldavs ZG; Chiller TM; Park BJ; Cleveland AA; Lockhart SR
Antimicrob Agents Chemother; 2014 Aug; 58(8):4690-6. PubMed ID: 24890592
[TBL] [Abstract][Full Text] [Related]
40. Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit.
Ghannoum MA; Chen A; Buhari M; Chandra J; Mukherjee PK; Baxa D; Golembieski A; Vazquez JA
Clin Microbiol Infect; 2009 Mar; 15(3):274-9. PubMed ID: 19210699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
